The practice of medicine has evolved significantly over the centuries, from generalized treatments based on limited knowledge to highly personalized and data-driven approaches. This evolution is often broken-down into three stages: Medicine 1.0, 2.0, and the current era of Medicine 3.0, also known as precision medicine. While these concepts are often discussed in human healthcare, they are increasingly relevant in veterinary medicine, particularly in equine practice. The shift to precision medicine has opened up new possibilities for diagnosing and managing complex conditions such as equine metabolic syndrome (EMS) and laminitis, diseases where a one-size-fits-all approach has proven inadequate.
Medicine 1.0: The Era of Generalized Care
Medicine 1.0 refers to the earliest phase of medical practice, characterized by a broad, one-size-fits-all approach to treatment. In this era, diagnostics were rudimentary, and treatments were often based on observation and anecdotal evidence rather than scientific data. In equine medicine, this approach translated into generalized dietary recommendations, basic farriery techniques, and symptomatic treatments for conditions like colic, laminitis, or respiratory infections.
For example, laminitis—a painful and potentially life-threatening condition affecting the hooves—was historically treated with rest, supportive shoeing, and anti-inflammatory drugs. These interventions were applied universally, regardless of the underlying cause of the condition. While these methods provided symptomatic relief, they often failed to address the root causes, leading to recurrent episodes and poor long-term outcomes.
Medicine 2.0: Evidence-Based Practice
The transition to Medicine 2.0 marked a significant leap forward, driven by advancements in scientific research, diagnostic tools, and technology. This era embraced evidence-based medicine, where clinical decisions were informed by a combination of scientific studies, clinical expertise, and patient circumstances. Veterinary medicine began to move away from generalized care, incorporating research findings and diagnostic technologies to tailor treatments more effectively.
In the context of equine metabolic syndrome (EMS), Medicine 2.0 brought a deeper understanding of the disease’s pathophysiology. EMS, a condition characterized by insulin dysregulation, obesity, and an increased risk of laminitis, became a focal point of research. Evidence-based approaches emphasized dietary management, weight loss programs, and the use of diagnostic tools such as oral sugar tests (OST) and insulin assays to identify horses at risk.
For instance, instead of broadly recommending the same diets for all horses with laminitis, veterinarians began using diagnostic testing to identify insulin-dysregulated horses who would benefit most from dietary interventions. This targeted approach improved outcomes and allowed for more precise management of EMS.
Medicine 3.0: The Era of Precision Medicine
The current era, Medicine 3.0, builds upon the foundation of evidence-based practice, incorporating advanced diagnostic tools, nuanced clinical expertise, and individualized care to create a highly personalized approach. Precision medicine focuses on understanding the unique biological and environmental factors affecting each patient and tailoring interventions accordingly.
In equine veterinary medicine, precision medicine is becoming increasingly relevant as practitioners recognize that managing EMS and laminitis requires a departure from standardized protocols. While guidelines and flow charts can be valuable for those less experienced or in settings where rapid decision-making is needed, they often fail to account for the individual variability between horses. Precision medicine emphasizes the importance of nuanced, tailored approaches to diagnosis and treatment.
Tailored Diagnostic Testing in EMS and Laminitis
Precision medicine in equine practice begins with tailored diagnostic testing, which allows veterinarians to understand the specific characteristics and risks associated with each horse. This level of detail is crucial for managing EMS, where clinical presentations and risk factors can vary widely.
- Targeted Insulin Testing:
Diagnostic tests such as the oral sugar test (OST) and fed-insulin concentrations provide insights into how a horse’s body regulates insulin. In precision medicine, the selection of tests and their interpretation are carefully tailored to the individual horse, considering factors such as age, breed, body condition, and current diet. This ensures that diagnostic efforts are focused on determining the horse’s risk for laminitis based on its current management in the most cost-effective method possible. This provides a timely diagnosis which allows for tailored management plans without breaking the owner’s bank.
- Risk Stratification:
Interpretation of insulin results requires a nuanced approach and are based on several factors such as the clinical presentation, breed, genetics and management. For example, a fed-insulin result of 47uIU/ml might be interpreted quite differently in a miniature pony versus a Quarter horse, whereas this might be considered ‘normal’ for both horses in a medicine 2.0 era. A tailored approach allow us to stratify risk and prioritize interventions for high-risk horses.
- Environmental and Lifestyle Assessment:
Precision medicine goes beyond laboratory testing to include an evaluation of the horse’s environment, diet, and activity levels. For instance, a horse on pasture may have significantly different risk factors compared to one kept on a dry lot. Diagnostic efforts often include forage analysis, body condition scoring, and diagnostic imaging to create a comprehensive picture of the horse’s health.
Pharmacological Interventions: From Metformin to SGLT2 Inhibitors
Pharmacological options have also evolved significantly in the management of EMS. Historically, metformin was a go-to option for veterinarians, based on its success in human medicine. However, studies have shown that metformin is largely ineffective in the majority of horses. Its failure to reduce insulin concentrations in many animals makes it a less-than-ideal choice for managing insulin dysregulation, especially in a horse who is currently suffering from laminitis.
This has paved the way for the use of SGLT2 inhibitors, a newer class of drugs originally developed for humans with type 2 diabetes. Drugs like ertugliflozin, canagliflozin, velagliflozin and dapagliflozin have shown promise in reducing insulin levels by promoting glucose excretion through the urine. However, while these medications represent a significant advancement, their use in horses is still in its infancy and requires careful management. Importantly, although all these drugs belong to the same class, our clinical experience indicates that individual horses may respond differently to different doses and different drugs. This underscores the necessity for the prescribing veterinarian to have a thorough understanding of the pharmacology of these medications to select the most appropriate option for each individual horse.
- Safety and Monitoring
Baseline bloodwork, including renal and hepatic function tests, and measurement of triglycerides should always be performed before starting treatment. Ongoing monitoring is also essential, as some well-documented side-effects should not be ignored. SGLT2 inhibitors are powerful tools but are only as safe as the knowledge and experience of the veterinarians prescribing them.
- Tailored Monitoring Plans
Each horse receiving SGLT2 inhibitors requires a tailored monitoring plan. This might include periodic rechecks of lameness, body condition and laboratory testing (insulin and triglyceride levels, as well as kidney and liver markers) to ensure the drug is not causing harm. The frequency and scope of these evaluations depend on the horse’s initial health status, the dosage used, and the response to treatment.
- Importance of Diet and Management
It is critical to emphasize that SGLT2 inhibitors are not a magic bullet. Their effectiveness is significantly reduced if they are not used alongside appropriate dietary, management and farriery interventions. Moreover, adjustments in diet are usually necessary for most horses receiving these medications to prevent side effects and optimize outcomes.
The use of SGLT2 inhibitors reflects the principles of precision medicine, where interventions are tailored to the individual horse’s needs. However, this requires veterinarians to take a holistic approach, integrating pharmacology with diet, exercise, and overall management.
Individualized Hoof Care and Farriery
Laminitis management often requires extensive collaboration between veterinarians and farriers, and precision medicine has transformed how hoof care is approached. No longer is the heart bar shoe the default solution for every horse with laminitis. Today, veterinarians and farriers have access to a plethora of therapeutic foot support options, including:
- Conventional Shoes and Pads: Traditional approaches with modifications tailored to the horse’s needs.
- Glue-On Shoes: Ideal for horses with compromised hoof walls, offering support without the need for nails.
- Clogs: Designed to offload weight from the laminae and provide substantial comfort in some cases.
- Therapeutic Boots: A versatile option that allows for easy adjustments and can be combined with a range of padding styles for additional support.
This diversity in hoof care options reflects the understanding that there is no one-size-fits-all solution for laminitis. Each horse requires an individualized approach, which may involve a degree of trial and error to determine what works best. Some horses may respond well to boots, while others may be more comfortable with glue-on shoes or a different style of boot and padding. Achieving the desired outcome often requires a close working relationship between the veterinarian and farrier, as both expertise and collaboration are essential to providing the best support and comfort for the horse.
A Future of Personalized Equine Care
As equine veterinary medicine transitions into the era of precision medicine, the focus is no longer on treating diseases in isolation but on understanding and addressing the unique needs of each horse. For conditions like EMS and laminitis, this approach promises earlier detection, more effective treatments, and improved long-term outcomes.
At our practice, we are committed to the principles of precision medicine. By tailoring diagnostic testing, pharmacological interventions, hoof care, and management plans to the individual needs of each horse, we strive to achieve the best possible outcomes for our patients.
To ensure that we provide the highest level of care, we go to great lengths to invest in professional development and foster partnerships with experts from around the world. This allows us to stay at the forefront of advancements in equine medicine and bring the best possible solutions to our patients. By prioritizing precision medicine, we aim to not only treat diseases but also improve the quality of life for every horse entrusted to our care.